跳到主要导航 跳到搜索 跳到主要内容

Nanomedicines for the treatment of glaucoma: Current status and future perspectives

  • Zimeng Zhai
  • , Yiyun Cheng
  • , Jiaxu Hong*
  • *此作品的通讯作者
  • Fudan University
  • Guizhou Medical University
  • Science and Technology Commission of Shanghai Municipality
  • Ministry of Health of People's Republic of China

科研成果: 期刊稿件文献综述同行评审

摘要

Glaucoma is the global leading cause of irreversible blindness. It is a chronic progressive disorder and, therefore, often requires long-term management with drugs on patients’ discretion. However, there is a shortage of antiglaucoma drugs in the current market due to their low bioavailability. This is because there are multiple biological barriers of the human eyes, thereby leading to increased demands for frequent dosage regimen per day of these drugs, which could result in concomitant side effects and eventually reduced patient compliance. Recently, nanomedicines have become optimized alternatives to conventional ophthalmic formulations due to advantages of improved barrier permeability, sustained drug release, tissue targeting, and lowered systemic absorption of instilled medications. These merits provide the active ingredients in these nanomedicines an effective manner to reach the ideal concentrations at sites of damaged nerves, offering a promising platform for neuroprotective treatment of these conditions. In this study, nanomedicines and nanomedicine-based novel strategies for pharmacotherapy of glaucoma were reviewed, including liposomes, niosomes, nanoparticles, and dendrimers. This article intends to offer a comprehensive review of frontier progresses as well as hotspots and issues that appeared in the field of nanomedicines, which may enable a practical flourish in the future. Statement of significance: Recent novel pharmaceutical strategies toward glaucoma, a chronic blinding ocular disease that currently requires frequent daily dosage regimen, based on nanomedicines and nanomaterials have been comprehensively reviewed in this manuscript. The collection of field hotspots and issues in the late years should offer a quick grasp of the general concept and up-to-date threads upon the refinement of existing treatment patterns for glaucoma. Meanwhile, the Conclusion and Future Perspective section given at the end of the text brings out the possible shortages and opinions in terms of ideal research direction, which hopefully could facilitate a future practical flourish in the area.

源语言英语
页(从-至)41-56
页数16
期刊Acta Biomaterialia
125
DOI
出版状态已出版 - 15 4月 2021

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

指纹

探究 'Nanomedicines for the treatment of glaucoma: Current status and future perspectives' 的科研主题。它们共同构成独一无二的指纹。

引用此